Switzerland· 68733005
Jaypirca 100 mg, comprimés pelliculés
A bruton's tyrosine kinase (btk) inhibitors product containing pirtobrutinibum, registered in Switzerland by Eli Lilly (Suisse) SA and dispensed under Swissmedic category A. The same ATC class is registered in 3 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Pirtobrutinibum is registered in 3 of 19 countries.
Countries holding a registration under ATC L01EL (bruton's tyrosine kinase (btk) inhibitors), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 2 of them publish a price we can compare per daily dose
Pirtobrutinibum · ATC L01EL
3 / 19 countries
- Czechiaprice
- Denmark
- Switzerlandprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- pirtobrutinibum
- Manufacturer
- Eli Lilly (Suisse) SA
- Country
- Switzerland (CH)
- ATC code
- L01EL
- ATC class
- Bruton's tyrosine kinase (BTK) inhibitors
- Swissmedic category
- A
- Reimbursed
- No
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Pirtobrutinibum in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaJAYPIRCAEli Lilly Nederland B.V., Utrecht
- FinlandJaypircaEli Lilly Nederland B.V
- FranceJAYPIRCA 100 mg, comprimé pelliculéELI LILLY NEDERLAND BV (PAY-BAS)
- IrelandJaypirca 100 mg film-coated tabletsEli Lilly Nederland B.V.
- IcelandJaypircaEli Lilly Nederland B.V.*
- NetherlandsJaypirca 100 mg filmomhulde tablettenEli Lilly Nederland B.V.
- NorwayJaypircaEli Lilly Nederland B.V.
- PolandJaypircaEli Lilly Nederland B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Jaypirca
- Liechtenstein · Jaypirca
- Norway · Jaypirca
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d6300c1b-4364-40fa-94ad-e717021c48a2 GET /v1/drugs/d6300c1b-4364-40fa-94ad-e717021c48a2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{}See everything about pirtobrutinibum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.